Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis (vol 13, 1206768, 2023)

被引：0

作者：

Altaf, Reem ^{[1
]}

Ilyas, Umair ^{[2
]}

Ma, Anmei ^{[3
,4
,5
,6
]}

Shi, Meiqi ^{[3
,4
,5
]}

机构：

[1] Iqra Univ, Dept Pharm, Islamabad, Pakistan

[2] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Dept Pharmaceut, Islamabad, Pakistan

[3] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Peoples R China

[4] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Peoples R China

[5] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China

[6] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Nanjing 211198, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2024年 / 14卷

关键词：

NSCLC; mutational analysis; differentially expressed genes; microarray; bioinformatics;

D O I：

10.3389/fonc.2024.1377858

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1